| Autor: |
Ansari E; REPROCELL Europe Ltd, Glasgow, UK., Anderson B; Alucent Biomedical Inc., 675 Arapeen Dr Ste 102, Salt Lake City, UT, 84108, USA., Kauser K; Alucent Biomedical Inc., 675 Arapeen Dr Ste 102, Salt Lake City, UT, 84108, USA. kkauser@alucentbiomedical.com. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of cardiovascular translational research [J Cardiovasc Transl Res] 2021 Jun; Vol. 14 (3), pp. 441-448. Date of Electronic Publication: 2020 Aug 03. |
| DOI: |
10.1007/s12265-020-10063-y |
| Abstrakt: |
In this study, we investigated natural vascular scaffolding (NVS) treatment on vascular functionality using freshly isolated human popliteal arteries in vitro. Arteries were exposed to intraluminal NVS treatment consisting of a compound (4 amino-1,8-naphthalimide) photoactivated by a 450-nm light-emitting light fiber placed inside the artery. This procedure results in covalent linking between the extracellular matrix proteins to achieve a larger vessel diameter post-angioplasty and minimizing elastic recoil. Immediately following NVS treatment, rings were cut from the treated arteries and mounted in organ baths for contractility testing in response to U46619 and sodium nitroprusside. We also investigated the effect of NVS treatment on IL-6 cytokine release from vascular rings following a 4-h organoculture post-NVS treatment. Based on our results, we conclude that exposure of the vessels to NVS treatment does not adversely affect the contractile responsiveness of the vascular smooth muscle and exerts no pro-inflammatory effect. Graphical abstract. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink